Carnitine deficiency is associated with late-onset hypogonadism and depression in uremic men with hemodialysis

Aging Male

Volumn 17, Issue 4, 2014, Pages 238-242

  Fukami, Kei ^a   Yamagishi, Sho Ichi ^a   Sakai, Kazuko ^a   Kaida, Yusuke ^a   Minami, Aki ^a   Nakayama, Yosuke ^a   Ando, Ryotaro ^a   Obara, Nana ^a   Ueda, Seiji ^a   Wada, Yoshifumi ^b   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Wada Cardiovascular Clinic   (Japan)

Author keywords

AMS scale; Carnitine deficiency; Depression; Hemodialysis; Late onset hypogonadism; SDS

Indexed keywords

CARNITINE; TESTOSTERONE;

ADULT; AGING; AGING MALE SYMPTOMS SCALE; ARTICLE; CARDIOVASCULAR DISEASE; CARNITINE DEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOGONADISM; LINEAR REGRESSION ANALYSIS; MALE; QUESTIONNAIRE; RATING SCALE; SELF-RATING DEPRESSION SCALE; UREMIA; BLOOD; CASE CONTROL STUDY; COMPLICATION; DEFICIENCY; EUNUCHISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

CARNITINE; CASE-CONTROL STUDIES; DEPRESSION; EUNUCHISM; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; UREMIA;

EID: 84911904365     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2014.888053     Document Type: Article

References (33)

1. Carrero JJ, Stenvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant 2012;27:4030-41.
2. Carrero JJ, Qureshi AR, Parini P, et al. Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol 2009;20:613-20.
3. Kyriazis J, Tzanakis I, Stylianou K, et al. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant 2011;26:2971-7.
4. Agganis BT, Weiner DE, Giang LM, et al. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 2010;56:704-12.
5. Cukor D, Rosenthal DS, Jindal RM, et al. Depression is an important contributor to low medication adherence in hemodia-lyzed patients and transplant recipients. Kidney Int 2009;75: 1223-9.
6. Park HC, Yoon HB, Son MJ, et al. Depression and health-related quality of life in maintenance hemodialysis patients. Clin Nephrol 2010;73:374-80.
7. Martiny C, de Oliveira e Silva AC, Neto JP, Nardi AE. Factors associated with risk of suicide in patients with hemodialysis. Compr Psychiatry 2011;52:465-8.
8. Boulware LE, Liu Y, Fink NE, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol 2006;1:496-504.
9. Cano NJ, Heng AE, Pison C. Multimodal approach to malnutrition in malnourished maintenance hemodialysis patients. J Ren Nutr 2011;21:23-6.
10. Iglesias P, Carrero JJ, Díez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol 2012;25:31-42.
11. Fahed AC, Gholmieh JM, Azar ST. Connecting the lines between hypogonadism and atherosclerosis. Int J Endocrinol 2012;2012: 793-953.
12. Afsar B. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores. Int J Artif Organs 2013;36:314-9.
13. Chatterjee R, Wood S, McGarrigle HH, et al. A novel therapy with testosterone and sildenafil for erectile dysfunction in patients on renal dialysis or after renal transplantation. J Fam Plann Reprod Health Care 2004;30:88-90.
14. Francomano D, Bruzziches R, Natali M, et al. Cardiovascular effect of testosterone replacement therapy in aging male. Acta Biomed 2010;81:101-6.
15. Bøhmer T, Hoel P, Purvis K, Hansson V. Carnitine levels in human accessory sex organs. Arch Androl 1978;1:53-9.
16. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003;42:941-67.
17. Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis 2003;41:S13-26.
18. Adachi T, Fukami K, Yamagishi S, et al. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients. Nephrology (Carlton) 2012;17:689-94.
19. Cavallini G, Caracciolo S, Vitali G, et al. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 2004;63: 641-6.
20. Cruciani RA, Dvorkin E, Homel P, et al. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. J Pain Symptom Manage 2006;32:551-9.
21. Heinemann LA, Saad F, Zimmermann T, et al. The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes 2003;1:15.
22. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
23. Takahashi M, Ueda S, Misaki H, et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin Chem 1994;40:817-21.
24. Nagano M, Fukami K, Yamagishi S, et al. Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients. Nephrology (Carlton) 2011;16:299-303.
25. Daugirdas JT. Linear estimates of variable-volume, single-pool Kt/V: an analysis of error. Am J Kidney Dis 1993;22: 267-70.
26. Aydogan U, Aydogdu A, Akbulut H, et al. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J 2012;59: 1099-105.
27. Zhang XW, Liu ZH, Hu XW, et al. Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population. Chin Med J (Engl) 2012;125:3806-10.
28. Fernandes GV, dos Santos RR, Soares W, et al. The impact of erectile dysfunction on the quality of life of men undergoing hemodialysis and its association with depression. J Sex Med 2010; 7:4003-10.
29. Cavallini G, Modenini F, Vitali G, Koverech A. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. Urology 2005;66:1080-5.
30. Sayed-Ahmed MM, Khattab MM, Gad MZ, Mostafa N. L-carnitine prevents the progression of atherosclerotic lesions in hypercholes-terolaemic rabbits. Pharmacol Res 2001;44:235-42.
31. Shankar SS, Mirzamohammadi B, Walsh JP, Steinberg HO. L-carnitine may attenuate free fatty acid-induced endothelial dysfunction. Ann N Y Acad Sci 2004;1033:189-97.
32. Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly. Drugs Exp Clin Res 1994;20:169-76.
33. Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol 1986;24:511-6.